Key facts
- Notable investors include Coral Group.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Endo-Therapeutics
- ·The full record, as it builds
Funding rounds
No funding rounds for Endo-Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Endo-Therapeutics
Developer of endoscopy instruments designed to sell directly to surgery centers. The company's instruments include endoscopic biopsy forceps, cytology brushes, polypectomy snares, injection needles, foreign body retrieval baskets, and graspers, enabling physicians to treat their patients in an enhanced way and conduct successful surgeries.
- Sector
- Healthcare
- HQ
- Clearwater, FL, United States
- Founded
- 1992
- Employees
- 64
- Website
- endotherapeutics.com/
- Ownership
- Privately Held (backing)
Endo-Therapeutics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Endo-Therapeutics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Endo-Therapeutics in its N-PORT filings yet. We sweep new filings monthly.